249 related articles for article (PubMed ID: 25476122)
21. Malignant phyllodes tumor of the breast: a systematic review.
Lissidini G; Mulè A; Santoro A; Papa G; Nicosia L; Cassano E; Ashoor AA; Veronesi P; Pantanowitz L; Hornick JL; Rossi ED
Pathologica; 2022 Apr; 114(2):111-120. PubMed ID: 35414723
[TBL] [Abstract][Full Text] [Related]
22. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
23. Massive infarction of a recurrent phyllodes tumor of the breast: MRI-findings.
Verslegers I; Tjalma W; Van Goethem M; Colpaert C; Biltjes I; De Schepper AM; Parizel PM
JBR-BTR; 2004; 87(1):21-2. PubMed ID: 15055329
[TBL] [Abstract][Full Text] [Related]
24. [Phyllodes tumor of the breast: diagnostic and therapeutic problems].
Gangi S; Costanzo MP; Prosperini U; Lauria M; Furci M; Strano S; Basile F
Ann Ital Chir; 1996; 67(2):219-23. PubMed ID: 8929037
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical and molecular markers in breast phyllodes tumors.
Korcheva VB; Levine J; Beadling C; Warrick A; Countryman G; Olson NR; Heinrich MC; Corless CL; Troxell ML
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):119-25. PubMed ID: 21030860
[TBL] [Abstract][Full Text] [Related]
26. Breast carcinoma and phyllodes tumour: a case series.
Sin EI; Wong CY; Yong WS; Ong KW; Madhukumar P; Tan VK; Thike AA; Tan PH; Tan BK
J Clin Pathol; 2016 Apr; 69(4):364-9. PubMed ID: 26670744
[TBL] [Abstract][Full Text] [Related]
27. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
[TBL] [Abstract][Full Text] [Related]
28. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
[TBL] [Abstract][Full Text] [Related]
29. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
Koker MM; Kleer CG
Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
[TBL] [Abstract][Full Text] [Related]
30. Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours.
Tsang JY; Mendoza P; Lam CC; Yu AM; Putti TC; Karim RZ; Scolyer RA; Lee CS; Tan PH; Tse GM
Histopathology; 2012 Oct; 61(4):667-74. PubMed ID: 22571452
[TBL] [Abstract][Full Text] [Related]
31. Immunoprofile of metaplastic carcinomas of the breast.
Rakha EA; Coimbra ND; Hodi Z; Juneinah E; Ellis IO; Lee AH
Histopathology; 2017 May; 70(6):975-985. PubMed ID: 28029685
[TBL] [Abstract][Full Text] [Related]
32. Incidentally Discovered Extensive Squamous Metaplasia within Borderline Phyllodes Tumor: Presentation of a Rare Tumor.
Uğraş N; Tolunay Ş; Öz Atalay F; Gökgöz Ş
Turk Patoloji Derg; 2016; 32(1):47-50. PubMed ID: 24585350
[TBL] [Abstract][Full Text] [Related]
33. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
Tsai WC; Jin JS; Yu JC; Sheu LF
Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
[TBL] [Abstract][Full Text] [Related]
34. Fine needle aspiration cytology of adenomyoepithelioma of the breast: a case indistinguishable from phyllodes tumor in cytologic findings and clinical behavior.
Lee WY
Acta Cytol; 2000; 44(3):488-90. PubMed ID: 10834021
[No Abstract] [Full Text] [Related]
35. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.
Shpitz B; Bomstein Y; Sternberg A; Klein E; Tiomkin V; Kaufman A; Groisman G; Bernheim J
J Surg Oncol; 2002 Feb; 79(2):86-92. PubMed ID: 11815995
[TBL] [Abstract][Full Text] [Related]
36. Malignant phyllodes tumor of the breast with predominant chondrosarcomatous differentiation.
Vera-Sempere F; García-Martínez A
Pathol Res Pract; 2003; 199(12):841-5. PubMed ID: 14989497
[TBL] [Abstract][Full Text] [Related]
37. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
[TBL] [Abstract][Full Text] [Related]
38. Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast.
Chan YJ; Chen BF; Chang CL; Yang TL; Fan CC
J Chin Med Assoc; 2004 Jan; 67(1):3-8. PubMed ID: 15077883
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Molecular and Biological Characteristics of Phyllodes Tumors of the Breast.
Vorotnikov IK; Vysotskaya IV; Denchik DA; Letyagin VP; Davydov MM; Kirsanov VY; Kim EA; Buseva VS
Bull Exp Biol Med; 2020 Oct; 169(6):806-810. PubMed ID: 33098518
[TBL] [Abstract][Full Text] [Related]
40. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
Ibrahim WS
Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
